Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation.

De Angelis C, Mancusi A, Ruggeri L, Capanni M, Urbani E, Velardi A, Stern M.

Acta Haematol. 2011;126(1):13-20. doi: 10.1159/000323661. Epub 2011 Mar 17.

PMID:
21411985
2.

Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.

Romagné F, André P, Spee P, Zahn S, Anfossi N, Gauthier L, Capanni M, Ruggeri L, Benson DM Jr, Blaser BW, Della Chiesa M, Moretta A, Vivier E, Caligiuri MA, Velardi A, Wagtmann N.

Blood. 2009 Sep 24;114(13):2667-77. doi: 10.1182/blood-2009-02-206532. Epub 2009 Jun 24.

3.

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, Ruggeri L, Capanni M, Umansky V, Paschen A, Sucker A, Pende D, Groh V, Biassoni R, Höglund P, Kato M, Shibuya K, Schadendorf D, Anichini A, Ferrone S, Velardi A, Kärre K, Shibuya A, Carbone E, Colucci F.

J Clin Invest. 2009 May;119(5):1251-63. doi: 10.1172/JCI36022. Epub 2009 Apr 6.

4.

Occurrence of diffuse, poorly differentiated hepatocellular carcinoma during pegylated interferon plus ribavirin combination therapy for chronic hepatitis C.

Capanni M, Lorefice E, Benini MC, Biagini MR, Tozzi A, Salvadori E, Colagrande S, Surrenti C, Milani S.

J Chemother. 2008 Jun;20(3):380-4.

PMID:
18606596
5.

Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1.

Stern M, Ruggeri L, Capanni M, Mancusi A, Velardi A.

Blood. 2008 Aug 1;112(3):708-10. doi: 10.1182/blood-2008-02-137521. Epub 2008 May 23.

6.

Fatigue in primary biliary cirrhosis: a possible role of comorbidities.

Biagini MR, Tozzi A, Milani S, Grippo A, Amantini A, Capanni M, Galli A, Surrenti C.

Eur J Gastroenterol Hepatol. 2008 Feb;20(2):122-6. doi: 10.1097/MEG.0b013e3282f1cbda.

PMID:
18188032
7.

NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation.

Ruggeri L, Mancusi A, Burchielli E, Capanni M, Carotti A, Aloisi T, Aversa F, Martelli MF, Velardi A.

Blood Cells Mol Dis. 2008 Jan-Feb;40(1):84-90. Epub 2007 Oct 26.

PMID:
17964828
8.

Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk.

Pirro M, Schillaci G, Bagaglia F, Menecali C, Paltriccia R, Mannarino MR, Capanni M, Velardi A, Mannarino E.

Atherosclerosis. 2008 Apr;197(2):757-67. Epub 2007 Aug 27.

PMID:
17720166
9.

Association of plasma homocysteine with bone mineral density in postmenopausal women with osteoporosis or osteopenia affected by primary biliary cirrhosis.

Biagini MR, Tozzi A, Bongini E, Capanni M, Galli A, Milani S, Surrenti C.

J Clin Gastroenterol. 2007 Jul;41(6):635. No abstract available.

PMID:
17577123
10.

Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

Ruggeri L, Mancusi A, Capanni M, Urbani E, Carotti A, Aloisi T, Stern M, Pende D, Perruccio K, Burchielli E, Topini F, Bianchi E, Aversa F, Martelli MF, Velardi A.

Blood. 2007 Jul 1;110(1):433-40. Epub 2007 Mar 19.

11.

Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia.

Pirro M, Schillaci G, Paltriccia R, Bagaglia F, Menecali C, Mannarino MR, Capanni M, Velardi A, Mannarino E.

Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2530-5. Epub 2006 Aug 31.

PMID:
16946129
12.

Pegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients.

Taliani G, Gemignani G, Ferrari C, Aceti A, Bartolozzi D, Blanc PL, Capanni M, Esperti F, Forte P, Guadagnino V, Mari T, Marino N, Milani S, Pasquazzi C, Rosina F, Tacconi D, Toti M, Zignego AL, Messerini L, Stroffolini T; Nonresponder Retreatment Group.

Gastroenterology. 2006 Apr;130(4):1098-106.

PMID:
16618404
13.

Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study.

Capanni M, Calella F, Biagini MR, Genise S, Raimondi L, Bedogni G, Svegliati-Baroni G, Sofi F, Milani S, Abbate R, Surrenti C, Casini A.

Aliment Pharmacol Ther. 2006 Apr 15;23(8):1143-51.

14.

Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis.

Biagini MR, Tozzi A, Marcucci R, Paniccia R, Fedi S, Milani S, Galli A, Ceni E, Capanni M, Manta R, Abbate R, Surrenti C.

World J Gastroenterol. 2006 Mar 14;12(10):1607-12.

15.

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation.

Perruccio K, Tosti A, Burchielli E, Topini F, Ruggeri L, Carotti A, Capanni M, Urbani E, Mancusi A, Aversa F, Martelli MF, Romani L, Velardi A.

Blood. 2005 Dec 15;106(13):4397-406. Epub 2005 Aug 25.

16.

The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation.

Ruggeri L, Capanni M, Mancusi A, Martelli MF, Velardi A.

Transpl Immunol. 2005 Aug;14(3-4):203-6. Review.

PMID:
15982564
17.

Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis C.

Taliani G, Biliotti E, Capanni M, Tozzi A, Bresci S, Pimpinelli N.

J Chemother. 2005 Apr;17(2):212-4.

PMID:
15920908
18.

Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer.

Ruggeri L, Mancusi A, Capanni M, Martelli MF, Velardi A.

Curr Opin Immunol. 2005 Apr;17(2):211-7. Review.

PMID:
15766683
19.

Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.

Ruggeri L, Capanni M, Mancusi A, Perruccio K, Burchielli E, Martelli MF, Velardi A.

Int J Hematol. 2005 Jan;81(1):13-7. Review.

PMID:
15717682
20.

Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation.

Ruggeri L, Capanni M, Mancusi A, Urbani E, Perruccio K, Burchielli E, Tosti A, Topini F, Aversa F, Martelli MF, Velardi A.

Blood Cells Mol Dis. 2004 Nov-Dec;33(3):216-21. Review.

PMID:
15528134
21.

Natural killer cells as a therapeutic tool in mismatched transplantation.

Ruggeri L, Capanni M, Mancusi A, Aversa F, Martelli MF, Velardi A.

Best Pract Res Clin Haematol. 2004 Sep;17(3):427-38. Review.

PMID:
15498714
22.

Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation.

Velardi A, Ruggeri L, Capanni M, Mancusi A, Perruccio K, Aversa F, Martelli MF.

Hematol J. 2004;5 Suppl 3:S87-90. Review. No abstract available.

PMID:
15190285
23.

Helicobacter pylori cag pathogenicity island is associated with reduced expression of interleukin-4 (IL-4) mRNA and modulation of the IL-4delta2 mRNA isoform in human gastric mucosa.

Orsini B, Ottanelli B, Amedei A, Surrenti E, Capanni M, Del Prete G, Amorosi A, Milani S, D'Elios MM, Surrenti C.

Infect Immun. 2003 Nov;71(11):6664-7.

24.

A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C.

Fattovich G, Zagni I, Minola E, Felder M, Rovere P, Carlotto A, Suppressa S, Miracolo A, Paternoster C, Rizzo C, Rossini A, Benedetti P, Capanni M, Ferrara C, Costa P, Bertin T, Pantalena M, Lomonaco L, Scattolini C, Mazzella G, Giusti M, Boccia S, Milani S, Marin R, Lisa Ribero M, Tagger A.

J Hepatol. 2003 Nov;39(5):843-9.

PMID:
14568269
25.

Innate immunity against hematological malignancies.

Ruggeri L, Capanni M, Tosti A, Urbani E, Posati S, Aversa F, Martelli MF, Velardi A.

Cytotherapy. 2002;4(4):343-6. Review.

PMID:
12396834
26.

Need of more frequent International Normalized Ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination.

Poli D, Chiarugi L, Capanni M, Antonucci E, Abbate R, Gensini GF, Prisco D.

Blood Coagul Fibrinolysis. 2002 Jun;13(4):297-300.

PMID:
12032394
27.

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.

Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A.

Science. 2002 Mar 15;295(5562):2097-100.

28.

Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA.

Prisco D, Fedi S, Antonucci E, Capanni M, Chiarugi L, Chioccioli M, Falai M, Giglioli C, Abbate R, Gensini GF.

Thromb Res. 2001 Nov 1;104(3):181-6.

PMID:
11672760
29.

Cellular therapy: exploiting NK cell alloreactivity in transplantation.

Ruggeri L, Capanni M, Martelli MF, Velardi A.

Curr Opin Hematol. 2001 Nov;8(6):355-9. Review.

PMID:
11604575
30.

Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants.

Volpi I, Perruccio K, Tosti A, Capanni M, Ruggeri L, Posati S, Aversa F, Tabilio A, Romani L, Martelli MF, Velardi A.

Blood. 2001 Apr 15;97(8):2514-21.

31.

Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty.

Chiarugi L, Prisco D, Antonucci E, Capanni M, Fedi S, Liotta AA, Margheri M, Simonetti I, Gensini GF, Abbate R.

Atherosclerosis. 2001 Jan;154(1):129-35.

PMID:
11137091
32.

Tissue factor and homocysteine levels in ischemic heart disease are associated with angiographically documented clinical recurrences after coronary angioplasty.

Marcucci R, Prisco D, Brunelli T, Pepe G, Gori AM, Fedi S, Capanni M, Simonetti I, Federici G, Pastore A, Abbate R, Gensini GF.

Thromb Haemost. 2000 Jun;83(6):826-32.

PMID:
10896233
33.

The pre-procedural platelet state predicts clinical recurrence after coronary angioplasty.

Capanni M, Prisco D, Antonucci E, Chiarugi L, Boddi V, Abbate R, Giglioli C, Dabizzi RP, Margheri M, Simonetti I, Gensini GF.

Int J Clin Lab Res. 1999;29(4):145-9.

PMID:
10784375
34.

[Relationship between hyperhomocysteinemia and endothelial activation in patients with obliterative arteriopathy of the legs].

Rogolino A, Farsi A, Brunelli T, Ilari I, Capanni M, Domeneghetti MP, Dorigo W, Lombardi R, Pulli R, Pratesi C, Gensini GF.

Minerva Cardioangiol. 1999 Dec;47(12):583. Italian. No abstract available.

PMID:
10670214
35.

[Persistent generation of thrombin after coronary angioplasty].

Capanni M, Prisco D, Antonucci E, Chiarugi L, Giglioli C, Comeglio M, Fedi S, Falai M, Lombardi A, Gensini GF.

Minerva Cardioangiol. 1999 Dec;47(12):552-3. Italian. No abstract available.

PMID:
10670199
36.

[Changes in fibrinolysis after primary PTCA].

Antonucci E, Fedi S, Falai M, Lombardi A, Chioccioli M, Rogolino A, Simonetti I, Giglioli C, Capanni M, Chiarugi L, Gensini GF.

Minerva Cardioangiol. 1999 Dec;47(12):550-1. Italian. No abstract available.

PMID:
10670198
37.

Percutaneous transluminal coronary angioplasty procedure is associated to a decrease in transforming growth factor beta 1 levels.

Falciani M, Gori AM, Giusti B, Fedi S, Capanni M, Simonetti I, Margheri M, Prisco D, Abbate R, Gensini GF.

Thromb Haemost. 1999 Sep;82(3):1204-5. No abstract available.

PMID:
10494795
38.

High prevalence of anti-beta2 glycoprotein I antibodies in patients with ischemic heart disease.

Farsi A, Domeneghetti MP, Fedi S, Capanni M, Giusti B, Marcucci R, Giurlani L, Prisco D, Passaleva A, Gensini GF, Abbate R.

Autoimmunity. 1999;30(2):93-8.

PMID:
10435722
39.

Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.

Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K, Urbani E, Negrin RS, Martelli MF, Velardi A.

Blood. 1999 Jul 1;94(1):333-9.

40.

Natural killer cell-mediated lysis of autologous cells modified by gene therapy.

Liberatore C, Capanni M, Albi N, Volpi I, Urbani E, Ruggeri L, Mencarelli A, Grignani F, Velardi A.

J Exp Med. 1999 Jun 21;189(12):1855-62.

41.

Low-dose heparin pretreatment is not able to prevent clotting activation during coronary angiography.

Capanni M, Antonucci E, Chiarugi L, Giglioli C, Margheri M, Simonetti I, Prisco D, Abbate R, Gensini GF.

Thromb Res. 1998 Aug 1;91(3):151-3. No abstract available.

PMID:
9733159
42.

Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty.

Abbate R, Marcucci R, Camacho-Vanegas O, Pepe G, Gori AM, Capanni M, Simonetti I, Prisco D, Gensini GF.

Am J Cardiol. 1998 Aug 15;82(4):524-5.

PMID:
9723646
43.

The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD).

Abbate R, Sardi I, Pepe G, Marcucci R, Brunelli T, Prisco D, Fatini C, Capanni M, Simonetti I, Gensini GF.

Thromb Haemost. 1998 Apr;79(4):727-30.

PMID:
9569181

Supplemental Content

Loading ...
Support Center